News
Jacobio Pharma (1167.HK) announced that it has submitted the Phase I/II Investigational New Drug (IND) application for its BET inhibitor JAB-8263 for the treatment of autoimmune diseases ...
The issuer is solely responsible for the content of this announcement.
"No act of kindness, no matter how small, is ever wasted." We’re proud to share: As the rainy season swept through China, SLKOR teams took to the streets of Shenzhen’s Huaqiangbei yesterday. We ...
GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...
Zelos Group Inc, a Suzhou, Jiangsu province-based developer of Level 4 autonomous logistics vehicles, will ramp up efforts to ...
As President Trump steps up export controls to block China’s access to advanced semiconductors, Beijing and its tech sector ...
BEIJING] As Donald Trump brandishes US export controls on technology as a bargaining chip to wrest supplies of rare earth magnets from Beijing, China is showcasing what it can do without the most ...
Tiptoeing around sensitive topics like state subsidies, eight tech executives who addressed reporters downplayed the impact ...
Singapore Prime Minister Lawrence Wong made a five-day visit to China last week, a prominent display of friendly and ...
Linong Ji, a co-author and a diabetes researcher at Peking University People’s Hospital in Beijing, says ecnoglutide also improved ... mazdutide is manufactured by Innovent Biologics in Suzhou, China, ...
Start-ups rise fast where traditional manufacturing once ruled – powering Beijing’s innovation and self-reliance push.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results